Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invesque Ord Shs T.IVQ.U


Primary Symbol: T.IVQ Alternate Symbol(s):  T.IVQ.DB.U | T.IVQ.DB.V | MHIVF

Invesque Inc. is a healthcare real estate company. The Company is focused on investing in a portfolio of North American properties across the health care spectrum. The Company's portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties, which are operated under long-term leases and joint venture arrangements with operating partners. Its portfolio also includes investments in owner-occupied seniors housing properties in which the Company owns the real estate and provides management services through its subsidiary management company, Commonwealth Senior Living. The Company owns or has a majority interest in a portfolio of approximately 68 properties in the United States, comprised of 57 assisted living and memory care facilities, nine skilled nursing facilities and two medical office buildings.


TSX:IVQ - Post by User

Comment by Capharnaumon Oct 13, 2021 10:10pm
60 Views
Post# 34003714

RE:RE:Value of U debentures

RE:RE:Value of U debenturesAlso, if rejecting the deal was a matter of going concern, they would have been required to write it in the prospectus.

They clearly write that if the deal is rejected, they will fund it otherwise, citing cash, other debt, and at worst shares at a 5% discount (basically, you get $105.2 worth of shares per $100 of debentures if they were to fully pay with shares).

Since they already offered to pay 22% in cash, I doubt that if the deal gets rejected they pay less than that in cash (considering the dilution for their two big funds holding over 50% of commons).

Based on today's price, if the deal is rejected and they pay 100% in shares, the shares would have to drop 24% from the date of closing for holders to get less cash than the trade value today. If they pay 22% in cash, the shares would have to drop 37% from the date of closing for holders to get less cash than the trade value today.

This deal is proposed to protect the big funds that hold common shares (else the premium wouldn't be 300% on conversion) at the expense of the smaller holders of the debentures. Unfortunately, many smaller holders will bend over even if it's a terrible deal.
<< Previous
Bullboard Posts
Next >>